Dear Editor, Up to 30% of the depression cases can be named as refractory. 1 These cases are resistant even to electroconvulsive therapy (ECT). One possibility to overcome refractoriness is to potentiate ECT with a monoamine oxidase inhibitor (MAOI). Monaco et al. reported one of the first case series of patients (n = 26) taking low doses of tranylcypromine and undergoing ECT, with no additional adverse reactions. From the anesthesiological point of view, there is
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Eletroconvulsoterapia e inibidores da monoaminoxidase evidence that anesthesia is safe when performed in patients taking MAOI. 2, 3 The most common adverse reactions are hyperpyrexia, hypertension, and muscle twitching. Another shortcoming would be that the long-term use of MAOI may downregulate post-synaptic central and peripheral receptors activity ( , 1 and 2 adrenergic; 5HT1 and 5HT2), causing hypotension in the withdrawal process. The suggestion would be to keep the use of the drug (MAOI). 3 Dolenc et al. found 100 case reports of anesthesia and MAOI use in the literature, with few complications. When the basic recommendations for MAOI use were followed, the outcomes were positive. The authors themselves reported 4 cases, with no complications and good outcomes over depressive symptoms. The hemodynamic patterns did not differ from those registered in the first cycle of ECT. 4 We would like to describe a case of refractory depression treatment using ECT in a patient taking high doses of tranylcypromine: 
